As the only lab making the rabies virus at Northwestern University Feinberg School of Medicine, Steven DeVries, PhD, and Yongling Zhu, PhD, are using it to explore the retina.
More than 290 poster entries were submitted as part of the record-breaking eighth annual Lewis Landsberg Research Day.
A new drug developed by Northwestern Medicine® scientists prevented human prostate cancer cells from spreading to other tissues without any toxic effects to normal cells or tissues. The drug turns off the “go” switch in the cancer cells and immobilizes them.
Robert Fragen, MD, professor emeritus of anesthesiology, has written a book, “From Promise to Excellence: A History of the Department of Anesthesiology of Northwestern University Medical School from 1966-2010.”
Internationally known for her research on the mechanisms of birth defects, Patricia Donahoe, MD, professor of surgery at Harvard Medical School and director of the pediatric surgical research laboratories at Massachusetts General Hospital, presented the 16th annual Distinguished Women in Medicine and Science Lecture on March 22.
A genetic pathway previously known for its role in embryonic development and cancer has been identified as a target for systemic sclerosis, or scleroderma, therapy. The finding, discovered by medical school researchers, was recently published in the journal Arthritis & Rheumatism.
The number of American children leaving doctors’ offices with an attention deficit hyperactivity disorder diagnosis has risen 66 percent in 10 years, according to a new Northwestern Medicine study.
Northwestern University Feinberg School of Medicine has moved up one spot to No. 18 in the 2013 U.S. News & World Report rankings of top research-oriented medical schools in the country.
Northwestern University scientists have developed a powerful analytical method that directs stem cell differentiation. Researchers can use the method, called nanocombinatorics, to build enormous libraries of physical structures varying in size. Details of the method and proof of concept is published in the Proceedings of the National Academy of Sciences.
New ongoing research suggests organ transplant recipients may not require anti-rejection medication in the future thanks to the power of stem cells, which may prove to be able to be manipulated in mismatched kidney donor and recipient pairs to allow for successful transplantation without immunosuppressive drugs.